Faron Pharmaceuticals Oy FARN.L Stock
Faron Pharmaceuticals Oy Price Chart
Faron Pharmaceuticals Oy FARN.L Financial and Trading Overview
Faron Pharmaceuticals Oy stock price | 127.5 GBP |
Previous Close | 261 GBP |
Open | 254 GBP |
Bid | 256 GBP x 0 |
Ask | 266 GBP x 0 |
Day's Range | 254 - 256.1 GBP |
52 Week Range | 155 - 395 GBP |
Volume | 5K GBP |
Avg. Volume | 8.83K GBP |
Market Cap | 165.73M GBP |
Beta (5Y Monthly) | 0.067816 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.41 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.42 GBP |
FARN.L Valuation Measures
Enterprise Value | 162.37M GBP |
Trailing P/E | N/A |
Forward P/E | -23.281818 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 206.39204 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 202.206 |
Enterprise Value/EBITDA | -5.95 |
Trading Information
Faron Pharmaceuticals Oy Stock Price History
Beta (5Y Monthly) | 0.067816 |
52-Week Change | 26.08% |
S&P500 52-Week Change | 20.43% |
52 Week High | 395 GBP |
52 Week Low | 155 GBP |
50-Day Moving Average | 298.78 GBP |
200-Day Moving Average | 272.57 GBP |
FARN.L Share Statistics
Avg. Volume (3 month) | 8.83K GBP |
Avg. Daily Volume (10-Days) | 7.12K GBP |
Shares Outstanding | 63.5M |
Float | 33.79M |
Short Ratio | N/A |
% Held by Insiders | 45.14% |
% Held by Institutions | 13.47% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -3415.31% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -140.19% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 803K GBP |
Revenue Per Share (ttm) | 0.02 GBP |
Quarterly Revenue Growth (yoy) | -86.90% |
Gross Profit (ttm) | N/A |
EBITDA | -27288000 GBP |
Net Income Avi to Common (ttm) | -28730000 GBP |
Diluted EPS (ttm) | -0.44 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 6.99M GBP |
Total Cash Per Share (mrq) | 0.12 GBP |
Total Debt (mrq) | 13.27M GBP |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.929 |
Book Value Per Share (mrq) | -0.192 |
Cash Flow Statement
Operating Cash Flow (ttm) | -22993000 GBP |
Levered Free Cash Flow (ttm) | -12454750 GBP |
Profile of Faron Pharmaceuticals Oy
Country | United Kingdom |
State | N/A |
City | Turku |
Address | Joukahaisenkatu 6 B |
ZIP | 20520 |
Phone | 358 2469 5151 |
Website | https://www.faron.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 40 |
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. It also develops Haematokine, an investigational AOC3 inhibitor that is used for regenerative medicines in hematological malignancies, as well as chemotherapy induced suppression of the bone marrow. In addition, the company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.
Q&A For Faron Pharmaceuticals Oy Stock
What is a current FARN.L stock price?
Faron Pharmaceuticals Oy FARN.L stock price today per share is 127.5 GBP.
How to purchase Faron Pharmaceuticals Oy stock?
You can buy FARN.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Faron Pharmaceuticals Oy?
The stock symbol or ticker of Faron Pharmaceuticals Oy is FARN.L.
Which industry does the Faron Pharmaceuticals Oy company belong to?
The Faron Pharmaceuticals Oy industry is Biotechnology.
How many shares does Faron Pharmaceuticals Oy have in circulation?
The max supply of Faron Pharmaceuticals Oy shares is 720.08K.
What is Faron Pharmaceuticals Oy Price to Earnings Ratio (PE Ratio)?
Faron Pharmaceuticals Oy PE Ratio is now.
What was Faron Pharmaceuticals Oy earnings per share over the trailing 12 months (TTM)?
Faron Pharmaceuticals Oy EPS is -0.41 GBP over the trailing 12 months.
Which sector does the Faron Pharmaceuticals Oy company belong to?
The Faron Pharmaceuticals Oy sector is Healthcare.